Markets Starting To Worry About Stagflation. But The End Is Not Nigh
Markets Starting To Worry About Stagflation, But The End Is Not Nigh
Source link
Markets Starting To Worry About Stagflation, But The End Is Not Nigh
Source link
This article was written by Follow About My Writing: I am currently focused on income investing through either common shares, preferred shares, or bonds. I will occasionally break away and write about the economy at large or a special situation involving a company I’ve been researching in. I target two articles per week for publication on…
Hedge fund Coatue is putting their stake in the ground. They say AI is going to improve productivity and take down the US debt to GDP ratio. They think the Mag 7 will keep growing. But the next wave of big capital growth will come from different AI winners. The next wave of this tech…
Bloom Energy Corporation (NYSE:BE – Get Free Report) insider Maciej Kurzymski sold 2,474 shares of the company’s stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $70.47, for a total value of $174,342.78. Following the sale, the insider owned 106,374 shares of the company’s stock, valued at…
This is the second part of the complete user manual for iMManager. Market vs Pending Execution Managing Open Positions Managing Pending Orders Symbol Switch Manager Daily Risk Guard Trading Statistics Dashboard Closed Positions / History One Click Trading and Confirmations Important Notes Hotkeys Reference It is recommended to read Part 1 first for a complete…
Biome Australia Limited (BIO) is an Australian company that primarily operates in the “complementary medicine” industry. Biome Australia licences, develops and markets innovative, evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). Since incorporation, Biome Australia has launched ten products under the Activated Probiotic® brand including: a number of…
Epiminder Limited (ASX: EPI) is a Melbourne-based medtech company developing the Minder® system – the world’s first FDA-authorized implantable continuous EEG monitoring device for drug-resistant epilepsy. The fully subcutaneous implant records high-quality brain activity for months to years, enabling long-term seizure detection and remote clinical review. Founded in 2017 as a spin-out from the University…